Top Markets
Coin of the day
SD BioSensor, Inc SD BioSensor, Inc

SD BioSensor, Inc

137310
Clasificación en acciones #13253
SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced... SD BioSensor Inc., a global leader in in-vitro diagnostics, delivers advanced point-of-care testing solutions from its base in South Korea. The company's diverse product portfolio features the STANDARD Q rapid diagnostic platform, offering quick results for various parameters including COVID-19. For laboratory settings, they provide the STANDARD F, a multi-parametric, random-access fluorescence immunoassay system, and the STANDARD E, an ELISA-based solution ideal for extensive screening programs. Their STANDARD M system brings molecular diagnostics closer to the patient, comprising analyzers, assay menus, qPCR reagents, and nucleic acid extraction kits. Furthermore, the procell Dx range focuses on diagnosing infectious diseases such as tuberculosis and SARS-CoV-2, alongside assessing immune status through interferon-gamma release assays. Blood glucose meters also form part of their offerings. Founded in 2010, SD BioSensor is headquartered in Suwon.
Precio por acción
$4.23
Capitalización bursátil
$506.22M
Cambio (1 día)
-2.86%
Cambio (1 año)
-41.34%
País
KR
Comercio SD BioSensor, Inc (137310)

Categoría

Ganancias de SD BioSensor, Inc (137310)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di SD BioSensor, Inc, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de SD BioSensor, Inc desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$3.81B -
US
$4.11B -
FR
- -
JP
$1.59B -
US
- -
CH